Insulin Lispro-Aabc
4 NDCs across 1 manufacturer|0 Generic,4 Brand
Insulin Lispro-Aabc is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $90 million on Insulin Lispro-Aabc across 100,000 claims for 31,000 beneficiaries.
Insulin Lispro-Aabc is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $7.87 to $20.28 per ML — the most expensive product costs about 2.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$7.87 – $20.28
per ML
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Insulin Analog class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing INSULIN LISPRO-AABC
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LYUMJEV 200 UNIT/ML KWIKPEN | $20.2823 per ML | -0.03% |
LYUMJEV 100 UNIT/ML KWIKPEN | $10.1549 per ML | -0.02% |
LYUMJEV TEMPO PEN 100 UNIT/ML | $10.1381 per ML | — |
LYUMJEV 100 UNIT/ML VIAL | $7.8733 per ML | -0.04% |
Frequently Asked Questions
What is Insulin Lispro-Aabc used to treat?
Insulin Lispro-Aabc is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Insulin Lispro-Aabc?
In 2024, Medicare Part D spent $90 million on Insulin Lispro-Aabc across 100,000 claims for 31,000 beneficiaries.
How many Insulin Lispro-Aabc products are on the market?
The Insulin Lispro-Aabc drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Insulin Lispro-Aabc?
NADAC reference prices for Insulin Lispro-Aabc range from $7.8733 to $20.2823 per ML — the most expensive product costs about 2.6× the cheapest.
Which manufacturers make Insulin Lispro-Aabc?
1 manufacturer lists Insulin Lispro-Aabc in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (4).
How has the price of Insulin Lispro-Aabc changed recently?
Over the past 7 days, 0 Insulin Lispro-Aabc NDCs rose and 3 fell, with a market-wide average change of -0.0%.